Home Mainline IPOs Park Medi World IPO
Orion Industries logo

Park Medi World IPO

Open MainLine
BSE,NSE 10 December - 12 December 2025
Park Medi World Limited IPO is a book build issue of 920 Cr. The issue is a combination of fresh issue of 47530864 shares aggregating to 770 Cr and offer for sale of 9259259 shares aggregating to 150 Cr. Park Medi World Limited IPO opened for subscription on Dec 10, 2025 and closed on Dec 12, 2025. The allotment for the this IPO was finalized on Dec 15, 2025. IPO was listed on NSE and BSE on Dec 17, 2025. Park Medi World Limited IPO is set issue price band at ₹154 to ₹162 per share.

Current GMP

₹5 (+3.09%)

Price Band

₹ 154 – 162

Lot Size

92

Issue Size

₹920 Cr

Minimum Investment

₹14904 (92 Shares)

Listing Date

17 December 2025

Subscription

8.1x

About the Company


Incorporation: 2011
Type: Private Hospital Chain
Headquarters: North India

Park Medi World Limited is a leading healthcare provider operating under the ‘Park Hospitals’ brand. As of September 30, 2024, the company manages a network of 13 multi-super speciality hospitals across Haryana, Delhi, Punjab, and Rajasthan, with a total bed capacity of 3,000 beds.

Accreditations

  • All 13 hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH).
  • 7 hospitals hold accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL).

Medical Facilities & Infrastructure

  • Total Beds: 3,000
  • ICU Beds: 805
  • Operating Theatres (OTs): 63
  • Dedicated Cancer Units: 2
  • Oxygen Generation Plants: Installed across all hospitals

Key Specialities and Services

Park Hospitals offer over 30 super speciality and speciality services, including:

  • Internal Medicine
  • Neurology
  • Urology
  • Gastroenterology
  • General Surgery
  • Orthopaedics
  • Oncology
  • And other advanced medical disciplines

Hospital Network

Haryana: Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad
Delhi: New Delhi
Punjab: Patiala, Mohali
Rajasthan: Jaipur, Behror

Operational Performance

PeriodIn-Patient AdmissionsSix months ended Sept 30, 2024 | 40,368
FY 2024 | 73,284
FY 2023 | 73,084
FY 2022 | 62,106

Human Resources (as of September 30, 2024)

  • Doctors: 891
  • Nurses: 1,912
  • Medical Professionals: 671
  • Support Staff: 1,761

Summary:
Park Medi World Limited has established itself as one of North India’s prominent healthcare networks, offering high-quality, accredited medical services through its technologically advanced hospitals. With a robust infrastructure, a strong team of healthcare professionals, and a wide range of speciality services, the Park Hospitals group continues to strengthen its position in the regional healthcare sector.


Promoters

  1. Dr. Ajit Gupta 
  2. Dr. Ankit Gupta 
Promoters Holding

Holding Pre Issue

95.55%

Holding Post Issue

82.89%

Objects of the Issue

The Company Park Medi World IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.

  1. Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company and certain of our Subsidiaries 
  2. Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries, Park Medicity (NCR) and Blue Heavens, respectively 
  3. Funding capital expenditure for purchase of medical equipment by our Company and our certain Subsidiaries, Blue Heavens and Ratangiri 
  4. Unidentified inorganic acquisitions and General corporate purposes 

Address / Contact Info

Park Medi World Ltd.
12, Meera Enclave Near Keshopur,
Bus Depot, Outer Ring Road,
New Delhi 110018, Delhi
New Delhi, New Delhi, 110018
Phone: + 91 124 696 000
Email: company.secretary@parkhospital.in
Website: http://www.parkhospital.in/

IPO Snapshot

Face Value₹2 per share
Price Band₹ 154 – 162
Lot Size92
Issue TypeBook-building IPO
Sale TypeFresh Capital & Offer For Sale
Fresh Issue₹ 770.00 Cr
Offer for Sale₹ 150.00 Cr
Total Issue Size₹ 920.00 Cr
Listing AtBSE,NSE
IndustryHealthcare Services
SectorHealthcare
QIB Quota28.57%
BNII Quota14.29%
SNII Quota7.14%
Retail Quota50%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Park Medi World IPO is a Book-building IPO worth ₹920 crores. The price band is ₹154 to 162 per share. The IPO opens on Wed, Dec 10, 2025 and closes on Fri, Dec 12, 2025. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.

The Park Medi World IPO opens on Wed, Dec 10, 2025 and closes on Fri, Dec 12, 2025

Park Medi World IPO Price Band is ₹154 to 162.

Park Medi World IPO lot size is 92, and the minimum amount required for application is ₹14904.

The minimum investment for Park Medi World IPO is approximately ₹14904 based on the upper price band.

To apply for the Park Medi World IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Fri, Dec 12, 2025. After submission, funds are blocked until the basis of allotment of Park Medi World IPO is finalised.

Park Medi World IPO issue size is ₹920 crores.

Park Medi World IPO allotment date is Sat, Jun 27, 2026.

The registrar for Park Medi World IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website for IPO allotment status, refund processing, and other queries related to Park Medi World IPO through their official website or helpline.

The Park Medi World IPO GMP (Grey Market Premium) is ₹0 as of Wed, Dec 17, 2025. Based on the upper price band of ₹162 per share, the estimated Park Medi World IPO listing price is ₹162, indicating a potential listing gain of approximately 31% over the issue price.